ATE501725T1 - Parathormon-formulierungen und ihre anwendungen - Google Patents
Parathormon-formulierungen und ihre anwendungenInfo
- Publication number
- ATE501725T1 ATE501725T1 AT08842081T AT08842081T ATE501725T1 AT E501725 T1 ATE501725 T1 AT E501725T1 AT 08842081 T AT08842081 T AT 08842081T AT 08842081 T AT08842081 T AT 08842081T AT E501725 T1 ATE501725 T1 AT E501725T1
- Authority
- AT
- Austria
- Prior art keywords
- pth
- formulations
- parathormone
- applications
- ionic surfactant
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 102000003982 Parathyroid hormone Human genes 0.000 title 1
- 108090000445 Parathyroid hormone Proteins 0.000 title 1
- 239000000199 parathyroid hormone Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 4
- 239000002736 nonionic surfactant Substances 0.000 abstract 3
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 230000003078 antioxidant effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99606107P | 2007-10-26 | 2007-10-26 | |
| EP07021017A EP2052736A1 (de) | 2007-10-26 | 2007-10-26 | Parathyroidhormon-Formulierungen und ihre Verwendungen |
| PCT/EP2008/009069 WO2009053106A1 (en) | 2007-10-26 | 2008-10-27 | Parathyroid hormone formulations and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE501725T1 true ATE501725T1 (de) | 2011-04-15 |
Family
ID=39146901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08842081T ATE501725T1 (de) | 2007-10-26 | 2008-10-27 | Parathormon-formulierungen und ihre anwendungen |
Country Status (14)
| Country | Link |
|---|---|
| EP (2) | EP2052736A1 (de) |
| AT (1) | ATE501725T1 (de) |
| CY (1) | CY1112106T1 (de) |
| DE (1) | DE602008005643D1 (de) |
| DK (1) | DK2219665T3 (de) |
| ES (1) | ES2363272T3 (de) |
| HR (1) | HRP20110444T1 (de) |
| MX (1) | MX2010004388A (de) |
| PL (1) | PL2219665T3 (de) |
| PT (1) | PT2219665E (de) |
| RU (1) | RU2467762C2 (de) |
| SI (1) | SI2219665T1 (de) |
| WO (1) | WO2009053106A1 (de) |
| ZA (1) | ZA201002812B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6033280B2 (ja) * | 2011-04-22 | 2016-11-30 | ラジウス ヘルス，インコーポレイテッド | ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法 |
| WO2012158962A2 (en) * | 2011-05-18 | 2012-11-22 | Eumederis Pharmaceuticals, Inc. | Improved peptide pharmaceuticals |
| WO2013082418A1 (en) | 2011-11-30 | 2013-06-06 | 3M Innovative Properties Company | Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same |
| EP2883062B1 (de) * | 2012-08-13 | 2019-07-17 | Koninklijke Philips N.V. | Verwendung von antioxidantien in verfahren und mitteln zum nachweis von zielmolekülen in einer blutprobe |
| PL3122426T3 (pl) | 2014-03-28 | 2023-05-15 | Duke University | Leczenie raka sutka z zastosowaniem selektywnych modulatorów receptora estrogenowego |
| WO2016176665A1 (en) | 2015-04-29 | 2016-11-03 | Radius Health, Inc. | Methods of treating cancer |
| GB201602880D0 (en) | 2016-02-18 | 2016-04-06 | Ge Healthcare Uk Ltd | Method and composition for biomolecule stabilization |
| SMT202400423T1 (it) | 2016-03-01 | 2024-11-15 | Ascendis Pharma Bone Diseases As | Profarmaci di pth |
| PT3518982T (pt) | 2016-09-29 | 2025-01-29 | Ascendis Pharma Bone Diseases As | Descoberta da dose incremental em compostos de pth de libertação controlada |
| NZ792622A (en) | 2016-09-29 | 2025-08-29 | Ascendis Pharma Bone Diseases As | Pth compounds with low peak-to-trough ratios |
| RS64440B1 (sr) | 2016-09-29 | 2023-09-29 | Ascendis Pharma Bone Diseases As | Režim doziranja za pth jedinjenje sa kontrolisanim oslobađanjem |
| EP4374925A3 (de) | 2017-01-05 | 2025-01-15 | Radius Pharmaceuticals, Inc. | Polymorphe formen von rad9012-hcl |
| JP6577683B2 (ja) * | 2017-09-22 | 2019-09-18 | 旭化成ファーマ株式会社 | 安定性に優れるテリパラチド含有液状医薬組成物 |
| CN112423844B (zh) | 2018-07-04 | 2024-08-13 | 雷迪厄斯制药公司 | Rad1901-2hcl的多晶型形式 |
| CN112638407A (zh) * | 2018-07-30 | 2021-04-09 | 夏尔-Nps医药品有限公司 | 重组人类甲状旁腺素的改进稳定性调配物 |
| EP3923905A1 (de) * | 2019-02-11 | 2021-12-22 | Ascendis Pharma Bone Diseases A/S | Flüssige pharmazeutische formulierungen von pth-konjugaten |
| CN119390714A (zh) | 2019-02-12 | 2025-02-07 | 雷迪厄斯制药公司 | 方法和化合物 |
| CN112439054B (zh) * | 2019-08-28 | 2023-05-16 | 深圳翰宇药业股份有限公司 | 一种特立帕肽缓释凝胶注射液及其制备方法 |
| US20230190880A1 (en) * | 2020-03-30 | 2023-06-22 | Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd. | Formulations of Human Parathyroid Hormone (PTH) and Methods for Producing Same |
| CN113101275A (zh) * | 2021-05-27 | 2021-07-13 | 海南通用康力制药有限公司 | 注射用棓丙酯冻干粉针剂及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69429603T2 (de) * | 1993-09-22 | 2002-08-14 | Hisamitsu Pharmaceutical Co., Inc. | Iontophoresematrix |
| ZA966075B (en) * | 1995-07-27 | 1998-01-19 | Genentech Inc | Protein formulation. |
| JP4607010B2 (ja) * | 2003-02-28 | 2011-01-05 | 中外製薬株式会社 | タンパク質含有安定化製剤 |
| AU2004292954A1 (en) * | 2003-11-13 | 2005-06-09 | Alza Corporation | Composition and apparatus for transdermal delivery |
| WO2007044375A2 (en) * | 2005-10-06 | 2007-04-19 | Nastech Pharmaceutical Company Inc. | Pth formulations and methods of use |
| AU2006299887A1 (en) * | 2005-10-06 | 2007-04-19 | Nastech Pharmaceutical Company Inc. | PTH formulations and methods of use |
| US8093207B2 (en) * | 2005-12-09 | 2012-01-10 | Unigene Laboratories, Inc. | Fast-acting oral peptide pharmaceutical products |
-
2007
- 2007-10-26 EP EP07021017A patent/EP2052736A1/de not_active Withdrawn
-
2008
- 2008-10-27 AT AT08842081T patent/ATE501725T1/de active
- 2008-10-27 WO PCT/EP2008/009069 patent/WO2009053106A1/en not_active Ceased
- 2008-10-27 ES ES08842081T patent/ES2363272T3/es active Active
- 2008-10-27 EP EP08842081A patent/EP2219665B1/de active Active
- 2008-10-27 RU RU2010121165/15A patent/RU2467762C2/ru not_active IP Right Cessation
- 2008-10-27 DK DK08842081.5T patent/DK2219665T3/da active
- 2008-10-27 MX MX2010004388A patent/MX2010004388A/es active IP Right Grant
- 2008-10-27 HR HR20110444T patent/HRP20110444T1/hr unknown
- 2008-10-27 SI SI200830278T patent/SI2219665T1/sl unknown
- 2008-10-27 PL PL08842081T patent/PL2219665T3/pl unknown
- 2008-10-27 PT PT08842081T patent/PT2219665E/pt unknown
- 2008-10-27 DE DE602008005643T patent/DE602008005643D1/de active Active
-
2010
- 2010-04-21 ZA ZA2010/02812A patent/ZA201002812B/en unknown
-
2011
- 2011-06-16 CY CY20111100578T patent/CY1112106T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20110444T1 (hr) | 2011-08-31 |
| RU2467762C2 (ru) | 2012-11-27 |
| ZA201002812B (en) | 2011-12-28 |
| WO2009053106A1 (en) | 2009-04-30 |
| PT2219665E (pt) | 2011-06-29 |
| DK2219665T3 (da) | 2011-06-27 |
| PL2219665T3 (pl) | 2011-11-30 |
| MX2010004388A (es) | 2010-08-10 |
| EP2219665B1 (de) | 2011-03-16 |
| EP2052736A1 (de) | 2009-04-29 |
| DE602008005643D1 (de) | 2011-04-28 |
| RU2010121165A (ru) | 2011-12-10 |
| ES2363272T3 (es) | 2011-07-28 |
| SI2219665T1 (sl) | 2011-09-30 |
| HK1146465A1 (en) | 2011-06-10 |
| CY1112106T1 (el) | 2015-11-04 |
| EP2219665A1 (de) | 2010-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE501725T1 (de) | Parathormon-formulierungen und ihre anwendungen | |
| CO6311084A2 (es) | Combinaciones de compuestos activos que tienen propiedades insecticidas y acaricidas | |
| PA8595901A1 (es) | "n-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos | |
| CR11731A (es) | Composiciones y procedimientos para su preparación y uso | |
| BR112015023391A2 (pt) | formulações compreendendo conjugado droga-anticorpo anti-egfr | |
| WO2011049958A3 (en) | Modulation of gel temperature of poloxamer-containing formulations | |
| BRPI0516830A (pt) | composições de droga de liberação sustentada convenientemente implantáveis | |
| MX2010010508A (es) | Composiciones de absorcion de sebo. | |
| ECSP099514A (es) | Antagonistas de activina-actrii y usos para aumentar los niveles de glóbulos rojos | |
| ECSP099413A (es) | COMPUESTOS A BASE DE 4 - fenil - 6 - (2,2,2 - trifluoro - 1 - feniletoxi)pirimidina Y MÉTODOS PARA SU EMPLEO | |
| DK2201840T3 (da) | Hæmmere af Brutons tyrosinkinase | |
| WO2006096434A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders | |
| DK1819227T3 (da) | Farmaceutisk formulering af decitabin | |
| CO6280573A2 (es) | Concentrados en suspension basados en aceite | |
| BR112012009487A2 (pt) | formulações de espessante estáveis | |
| AR035284A1 (es) | Formulaciones en combinacion de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilizacion | |
| CU20060153A7 (es) | Nueva forma cristalina v de agomelatina, procedimiento para su preparación y composiciones farmacéuticas que las contienen | |
| CR9246A (es) | Formulaciones terapeuticas del factor de crecimiento de queratinocitos | |
| CY1108196T1 (el) | Αντιμικροβιακες φαρμακευτικες συνθεσεις χορηγουμενες απο το στομα | |
| CY1117237T1 (el) | Συνθεσεις σταθερων τιακουμυκινων | |
| CR9114A (es) | 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion | |
| CL2008001820A1 (es) | Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer. | |
| WO2006081363A3 (en) | Oral formulations for delivery of catecholic butanes including ndga compounds | |
| TN2011000261A1 (en) | Octreotide depot formulation with constantly high exposure levels | |
| NO20091517L (no) | Emulsjon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2219665 Country of ref document: EP |